 Behavioral complications drug treatment Parkinson disease variety neuropharmacologic agents anticholinergic drugs amantadine hydrochloride levodopa selegiline bromocriptine pergolide available treatment Parkinson disease patients dopaminergic agents develop visual hallucinations exhibit delusions experience anxiety confusional periods exhibit sexual behavior Anticholinergic drugs tendency confusional states dopaminergic compounds Elderly patients underlying dementia likely untoward side effects anti-parkinsonism treatment Dosage reduction optimum management strategy anti-psychotic agents necessary patients delusions lithium drug-induced mania Dopaminergic agents share property stimulation dopamine receptors action essential role neuropsychiatric effects